These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucocorticoid replacement therapy: are patients over treated and does it matter? Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP. Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031 [Abstract] [Full Text] [Related]
3. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. DeVile CJ, Stanhope R. Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370 [Abstract] [Full Text] [Related]
4. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism. Barbetta L, Dall'Asta C, Re T, Libè R, Costa E, Ambrosi B. J Endocrinol Invest; 2005 Jul; 28(7):632-7. PubMed ID: 16218046 [Abstract] [Full Text] [Related]
5. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Charmandari E, Johnston A, Brook CG, Hindmarsh PC. J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647 [Abstract] [Full Text] [Related]
6. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion. Bliesener N, Steckelbroeck S, Redel L, Klingmüller D. Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652 [Abstract] [Full Text] [Related]
7. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Maguire AM, Ambler GR, Moore B, McLean M, Falleti MG, Cowell CT. Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782 [Abstract] [Full Text] [Related]
8. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters. Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A, Sanmarti A. J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078 [Abstract] [Full Text] [Related]
10. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806 [Abstract] [Full Text] [Related]
11. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism. Wichers M, Springer W, Bidlingmaier F, Klingmüller D. Clin Endocrinol (Oxf); 1999 Jun; 50(6):759-65. PubMed ID: 10468948 [Abstract] [Full Text] [Related]
12. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study. Ceccato F, Barbot M, Lizzul L, Selmin E, Saller A, Albiger N, Betterle C, Boscaro M, Scaroni C. Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827 [Abstract] [Full Text] [Related]
13. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB. Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567 [Abstract] [Full Text] [Related]
17. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. Jung C, Greco S, Nguyen HH, Ho JT, Lewis JG, Torpy DJ, Inder WJ. BMC Endocr Disord; 2014 Nov 26; 14():91. PubMed ID: 25425285 [Abstract] [Full Text] [Related]
18. Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy. Haas CS, Rahvar AH, Danneberg S, Lehnert H, Moenig H, Harbeck B. Horm Metab Res; 2016 Sep 26; 48(9):571-4. PubMed ID: 27300473 [Abstract] [Full Text] [Related]
19. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome]. Tang TJ, Liu YP, Yu YR. Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep 26; 44(5):764-8. PubMed ID: 24325108 [Abstract] [Full Text] [Related]
20. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012? Debono M, Ross RJ. Clin Endocrinol (Oxf); 2013 May 26; 78(5):659-64. PubMed ID: 23194144 [Abstract] [Full Text] [Related] Page: [Next] [New Search]